These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5776422)

  • 1. Panel discussion: hospital intravenous additive programs. I. An analysis of a hospital's I.V. additive service.
    Schwarz MA
    Bull Parenter Drug Assoc; 1969; 23(2):78-80. PubMed ID: 5776422
    [No Abstract]   [Full Text] [Related]  

  • 2. Hazards surround I.V. admixtures.
    Dinel B
    Hosp Adm Can; 1978 Sep; 20(9):21, 23. PubMed ID: 10239185
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in intravenous additive programs; the report of a research study.
    Moravec DF
    Hosp Manage; 1970 Mar; 109(3):58-62. PubMed ID: 5414987
    [No Abstract]   [Full Text] [Related]  

  • 5. I.V. additives move to the pharmacy.
    Peritore SP; Rosenberg JM
    Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

  • 7. I. V. additive program belongs in the pharmacy.
    Brown RG
    Hospitals; 1969 Sep; 43(18):92-8. PubMed ID: 5809375
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous solutions: problems in dispensing, additive programs.
    Kenna FR
    Hosp Top; 1968 Dec; 46(12):49-52. PubMed ID: 5743236
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 11. Uses of a Xerox 800 electronic typing system in an intravenous additive service.
    Sargalski PJ
    Hosp Pharm; 1977 Jun; 12(6):285-7. PubMed ID: 10305443
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of I V additive programs to the parenteral industry.
    Latiolais CJ
    Bull Parenter Drug Assoc; 1970; 24(1):45-51. PubMed ID: 5415612
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacists and nurses benefit from an I.V. additive program.
    Ragland JB; Knoll KR
    Hospitals; 1968 Aug; 42(16):136-40. PubMed ID: 5666020
    [No Abstract]   [Full Text] [Related]  

  • 14. Data processing system supplies intravenous additive information.
    Hodges TH; Allen SI
    Hospitals; 1968 Nov; 42(22):103-5. PubMed ID: 5688330
    [No Abstract]   [Full Text] [Related]  

  • 15. IV additive service.
    McLemore RA
    Hospitals; 1971 Mar; 45(6):96-8. PubMed ID: 5547690
    [No Abstract]   [Full Text] [Related]  

  • 16. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic pipetters: applications and cost considerations in I.V. admixture programs.
    Blackstone M; Hauser LD
    Hosp Mater Manage Q; 1980 Feb; 1(3):69-85. PubMed ID: 10309094
    [No Abstract]   [Full Text] [Related]  

  • 18. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of quality assurance in hospital pharmacy.
    Oakley RS; Bradham DD
    Am J Hosp Pharm; 1983 Jan; 40(1):53-63. PubMed ID: 6823989
    [No Abstract]   [Full Text] [Related]  

  • 20. Outsourcing inpatient i.v. compounding: expense and medication error implications.
    Burruss RA; Carroll NV; Schraa C; Burton B
    Pharm Pract Manag Q; 1996 Oct; 16(3):52-9. PubMed ID: 10166235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.